Follicular Lymphoma (FL) is the second most common type of non-Hodgkin lymphoma and is considered to be the prototype of indolent lymphomas. Histologic transformation into an aggressive lymphoma, which is expected to occur at a rate of 2 to 3% each year, is associated with rapid progression, treatment resistance, and poor prognosis. Recent modifications to the physiopathologic mechanism of transformed follicular lymphoma (t-FL) have been proposed, including genetic and epigenetic mechanisms as well as a role for the microenvironment. Although t-FL is considered a devastating complication, as it is associated with treatment-refractory disease and a dismal outcome, recent data in the rituximab era have suggested that not only is the prognosis less severe than reported in the previous literature but the risk of transformation is also lower. Thus, this study aimed to review the most recent research on t-FL in an attempt to better understand the clinical meaning of transformation from FL to diffuse large B cell lymphoma (DLBCL) and the impact of current treatment strategies on the curability of this intriguing subentity of lymphoma.

Transformed follicular lymphoma / Fischer, Thais; Zing, Natalia Pin Chuen; Chiattone, Carlos Sergio; Federico, Massimo; Luminari, Stefano. - In: ANNALS OF HEMATOLOGY. - ISSN 0939-5555. - 97:1(2018), pp. 17-29. [10.1007/s00277-017-3151-2]

Transformed follicular lymphoma

Federico, Massimo
Writing – Review & Editing
;
Luminari, Stefano
Writing – Original Draft Preparation
2018

Abstract

Follicular Lymphoma (FL) is the second most common type of non-Hodgkin lymphoma and is considered to be the prototype of indolent lymphomas. Histologic transformation into an aggressive lymphoma, which is expected to occur at a rate of 2 to 3% each year, is associated with rapid progression, treatment resistance, and poor prognosis. Recent modifications to the physiopathologic mechanism of transformed follicular lymphoma (t-FL) have been proposed, including genetic and epigenetic mechanisms as well as a role for the microenvironment. Although t-FL is considered a devastating complication, as it is associated with treatment-refractory disease and a dismal outcome, recent data in the rituximab era have suggested that not only is the prognosis less severe than reported in the previous literature but the risk of transformation is also lower. Thus, this study aimed to review the most recent research on t-FL in an attempt to better understand the clinical meaning of transformation from FL to diffuse large B cell lymphoma (DLBCL) and the impact of current treatment strategies on the curability of this intriguing subentity of lymphoma.
2018
18-ott-2017
97
1
17
29
Transformed follicular lymphoma / Fischer, Thais; Zing, Natalia Pin Chuen; Chiattone, Carlos Sergio; Federico, Massimo; Luminari, Stefano. - In: ANNALS OF HEMATOLOGY. - ISSN 0939-5555. - 97:1(2018), pp. 17-29. [10.1007/s00277-017-3151-2]
Fischer, Thais; Zing, Natalia Pin Chuen; Chiattone, Carlos Sergio; Federico, Massimo; Luminari, Stefano
File in questo prodotto:
File Dimensione Formato  
10.1007@s00277-017-3151-2.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 850.51 kB
Formato Adobe PDF
850.51 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1152780
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 46
social impact